Varied Growth Drivers Led Antipodes Global Value Strategy to Add Globus Medical (GMED) to Its Portfolio

1 day ago 1

Soumya Eswaran

Fri, November 14, 2025 astatine 7:21 AM CST 3 min read

Antipodes Partners precocious published its “Antipodes Global Value Strategy” third-quarter 2025 capitalist letter, highlighting the cardinal show stocks, portfolio changes, and the marketplace outlook. A transcript of the missive tin beryllium downloaded here. In the quarter, planetary equities roseate positively, supported by easing commercialized tensions, excitement astir AI, and expectations of complaint cuts by the Federal Reserve. Global equities gained +7.6% successful USD and +6.4% successful AUD, driven by cardinal slope involvement complaint reductions, caller US commercialized agreements, and beardown firm earnings. The Antipodes Global Value Strategy outperformed the benchmark during this 4th and showed adjacent greater outperformance for the twelvemonth to day and the 12 months ending September 30, 2025. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its third-quarter 2025 capitalist letter, Antipodes Global Value Strategy highlighted stocks specified arsenic Globus Medical, Inc. (NYSE:GMED). Globus Medical, Inc. (NYSE:GMED) is simply a aesculapian instrumentality institution that focuses connected the improvement of healthcare solutions for patients with musculoskeletal disorders. The one-month instrumentality of Globus Medical, Inc. (NYSE:GMED) was 40.97%, and its shares gained 3.56% of their worth implicit the past 52 weeks. On November 12, 2025, Globus Medical, Inc. (NYSE:GMED) banal closed astatine $83.99 per share, with a marketplace capitalization of $11.241 billion.

Antipodes Global Value Strategy stated the pursuing regarding Globus Medical, Inc. (NYSE:GMED) successful its 3rd 4th 2025 capitalist letter:

"We besides initiated a presumption successful Globus Medical, Inc. (NYSE:GMED), a starring aesculapian devices shaper with a apical 3 presumption successful spinal orthopedics devices, spinal surgical robots and trauma country devices. It is simply a pure-play relation successful the spinal market, taking marketplace stock done innovation and concern improvement to boost standard and capable merchandise gaps. Growth is supported by structural tailwinds successful spinal orthopedics including demographics, improving country occurrence rates with advances successful technology, enlargement into orthopedic adjacencies specified arsenic knees and hips, under-penetration of robotics successful spinal surgeries, and further enlargement into the spinal cord stimulation market. The institution has a beardown equilibrium sheet, is buying backmost banal and has capableness for concern improvement to enactment growth."

Globus Medical, Inc. (NYSE:GMED) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 49 hedge money portfolios held Globus Medical, Inc. (NYSE:GMED) astatine the extremity of the 2nd quarter, up from 45 successful the erstwhile quarter. In the 3rd 4th of 2025, the institution achieved income of $769 million, representing maturation of 22.9% compared to Q3 2024. While we admit the imaginable of Globus Medical, Inc. (NYSE:GMED) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.